FIGURE 3.
Emerging technologies for identifying improved patient‐specific treatments, illustrations of (A) CRISPR screening for identification of synthetic lethalities, (B) single‐cell technologies to identify cancer‐specific epigenetic/transcriptional changes and (C) patient‐specific organoid modeling as a basis for personalized drug screening and therapeutic discovery